v3.26.1
Shareholder’s Equity (Tables)
 6 Months Ended
Dec. 31, 2025
Shareholder’s Equity [Abstract]  
Schedule of Key Inputs Used to Estimate the Fair Value of Share Options

For the six months ended December 31, 2025 and 2024, key inputs used to estimate the fair value of share options on the grant dates are as follows:

   Options
granted in
June
2021		 
Risk-free interest rate   0.87%
Expected life of the options   6.25 years 
Expected volatility   64.75%
Expected dividend yield   0.00%
Fair value  $0.14*

 

Binomial option pricing model

 

   Options
granted in
January
2022		 
Fair value of the ordinary shares on the date of option grant  $0.84*
Risk-free interest rate   1.53% to 1.589%
Option life   10 years 
Expected volatility   88.68% to 94.17%
Expected dividend yield   0.00%
Exercise price  $0.84*
Expected early exercise multiple   2.80 

 

   Options
granted in
June
2025		 
Fair value of the ordinary shares on the date of option grant  $17.40 
Risk-free interest rate   4.23%
Option life   10 years 
Expected volatility   65.34%
Expected dividend yield   0.00%
Exercise price  $17.40 
Expected early exercise multiple   2.80 

 

* These have been restated for the 38-for-1 forward stock split.
Schedule of Activities Share Options

A summary of activities of the share options for the six months ended December 2025 are presented as follows:

 

   Number
of Share
Options		   Weighted
Average
Exercise
Price		   Weighted
Average
Grant-date Fair value		   Weighted
Average
Remaining
Contractual
Term		   Aggregate
Intrinsic
Value		 
       $   $   Year   $ 
Outstanding as of June 30, 2025   24,490,506    0.68    0.40    6.16    440,464,693 
Expired, forfeited or cancelled   (2,035,736)   0.25    0.14    5.55    (42,241,522)
Outstanding as of December 31, 2025   22,454,770    0.72    0.43    5.66    455,431,408 
Exercisable as of December 31, 2025   21,714,454    0.26    0.15    5.55    450,313,694 
Vested and Expected to Vest as of December 31, 2025   22,454,770    0.72    0.43    5.66    455,431,408 

 

A summary of activities of the share options for the six months ended December 2024 are presented as follows:

 

   Number
of Share
Options		   Weighted
Average
Exercise
Price		   Weighted
Average
Grant-date Fair value		   Weighted
Average
Remaining
Contractual
Term		   Aggregate
Intrinsic
Value		 
       $   $   Year   $ 
Outstanding as of June 30, 2024   28,673,014    0.26    0.15    7.06    
            -
 
Expired, forfeited or cancelled   (4,626,690)   0.25    0.14    6.55    
-
 
Outstanding as of December 31, 2024   24,046,324    0.26    0.16    6.56    
-
 
Exercisable as of December 31, 2024   18,395,534    0.26    0.15    6.55    
-
 
Vested and Expected to Vest as of December 31, 2024   24,046,324    0.26    0.16    6.56    
-